Northwestern Mutual Wealth Management
PETX

Northwestern Mutual Wealth Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-229
Closed -$2K – 2587
2016
Q3 		$2K Buy
+229
New +$1.9K ﹤0.01% 1986

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northwestern Mutual Wealth Management's PETX Position: Q4 2016 in Review

Northwestern Mutual Wealth Management sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2016, closing a stake of 229 shares — an estimated $2K sold.

Northwestern Mutual Wealth Management first reported a position in PETX in Q3 2016 and held it in 1 quarter. The position peaked at $2K in Q3 2016. 107 funds tracked by Wall St. Rank hold PETX as of Q4 2016.

  • Northwestern Mutual Wealth Management reported no remaining Aratana Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 229 Aratana Therapeutics, Inc. shares in Q4 2016, an estimated $2K.
  • Northwestern Mutual Wealth Management first reported a position in Aratana Therapeutics, Inc. in Q3 2016 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Aratana Therapeutics, Inc. position peaked at $2K in Q3 2016.
  • 107 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2016.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2016, filed 15 Feb 2017.